Scalping & Mid-Term Analysis for NVIDIA

Scalping & Mid-Term Analysis for NVIDIA

Market Overview:
Trend: NVIDIA is in a strong uptrend, recovering after a pullback.
Key Levels:
Resistance: $140 - $142
Support: $132 - $133 (weak), $127 (stronger)
Indicators:
MACD: Bullish momentum, but slightly overextended.
EMA: NVDA is above the 200 EMA, confirming bullish dominance.
RSI: At 70.69, indicating near overbought territory.
? Scalping Strategy:
? 1. Momentum Scalping (Trending Market)
Why? NVIDIA is rallying with strong bullish pressure.
How?
Buy near $135 - $136, aiming for a scalp to $140 - $142.
Sell near $142, as resistance may slow down momentum.
Stop-loss below $134, in case of a pullback.
? 2. Breakout Scalping (If Resistance is Broken)
Trigger: A breakout above $142 or breakdown below $133.
Execution:
If NVDA breaks $142, scalp long targeting $145 - $148.
If NVDA drops below $133, scalp short to $127 - $125.
? 3. EMA Scalping
Why? NVDA is testing the 9 EMA for support, meaning dips could be buy opportunities.
Execution:
Buy on EMA bounce (~$135 - $136) for a quick move higher.
Short if price rejects resistance (~$140 - $142).
? Mid-Term Trend Forecast (1-3 Weeks)
Bias: Bullish → Neutral
Why?
Strong recovery from support, signaling buyers are in control.
RSI near overbought levels, meaning a pullback is possible before continuation.
If NVDA doesn’t break $142+, expect a retrace to $133 - $127 before another leg up.
Only a break above $145 will confirm further bullish extension.
? News & Market Context:
Tech sector strength driving NVDA, adding to momentum.
Earnings season approaching, could introduce volatility.
Market sentiment remains risk-on, favoring further upside.
? Decision: Enter or Stay Out?
? Short-term: Scalping is viable, but watch resistance at $140 - $142.
? Mid-term: Bullish unless NVDA fails to hold above $133.
? Ideal Play: Scalp long on dips but lock profits near resistance.

? Final Verdict:
NVIDIA is strong, but a pullback to $133 - $127 is possible before a breakout. Above $142, expect $145+ next. ?

Read More

Share:

Latest News